Results 61 to 70 of about 3,215 (175)

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

Molecular Oncology, Volume 20, Issue 1, Page 117-133, January 2026.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat, Marc Arbyn, David Baldwin, Xavier Castells, Solveig Hofvind, Urska Ivanus, Carlo Senore, Esther Toes‐Zoutendijk, Carlijn van der Aalst, Carlos Canelo‐Aybar, Fiorella Karina Fernández‐Sáenz, Ariadna Feliu, Hajo Zeeb, Andre L. Carvalho, Erica D'Souza, David Ritchie, Carolina Espina, Iris Lansdorp‐Vogelaar, Andrea DeCensi   +18 more
wiley   +1 more source

Dydrogesterone

, 2019
The pharmacological and physiological profiles of progestogens used for luteal phase support during assisted reproductive technology are likely to be important in guiding clinical choice towards the most appropriate treatment option. Various micronized progesterone formulations with differing pharmacological profiles have been investigated for several ...
Griesinger, Georg, Tournaye, Herman, Macklon, Nick, Petraglia, Felice, Arck, Petra, Blockeel, Christophe, van Amsterdam, Peter, Pexman-Fieth, Claire, Fauser, Bart Cjm   +8 more
openaire   +1 more source

Subchorionic hemorrhage treatment with dydrogesterone

Gynecological Endocrinology, 2007
The objective of the study was to evaluate the efficacy of progestogenic therapy for the prevention of spontaneous abortions in patients with subchorionic hemorrhage. One hundred pregnant women with bleeding and ultrasonographic evidence of subchorionic hematoma were treated with oral dydrogesterone 40 mg/day.
openaire   +2 more sources

MENOPAUSAL HORMONE THERAPY WITH DYDROGESTERONE: ASPECTS OF EFFICACY AND SAFETY OF ULTRA-LOW DOSES

Медицинский совет, 2017
A number of studies have shown that menopausal hormone therapy (MHT), consisting of 1 mg 17ß-estradiol and 5 mg dydrogesterone, is effective to reduce the severity of menopausal symptoms and increases bone mineral density in postmenopausal women [1] and ...
A. A. Smetnik
doaj   +1 more source

Intrauterine hematomas as a reason of complicated pregnancy course

Медицинский совет, 2016
The attitude of obstetricians-gynecologists to intrauterine hematoma has undergone a serious metamorphosis over the past 15–20 years. The first systematic surveys did not detect a risk of hemorrhage for a future pregnancy, if the embryo/fetus «survived ...
I. V. Kuznetsova
doaj   +1 more source

Combined effect of letrozole and dydrogesterone versus dydrogesterone alone for relieving pain in patients with endometriosis

Journal of Medicine in Scientific Research
Background Endometriosis is a medical condition in women caused by the growth of active endometrial tissue outside the uterine cavity. It predominantly affects women of reproductive age and typically manifests as dysmenorrhea, dyspareunia, chronic pelvic
Mohamed M.H. Elwakeel, Mohamed A.T. Elsharawy, Abdelghaffar S Dawod, Dina G ElKhouly   +3 more
doaj   +1 more source

Immunotherapy for recurrent miscarriage due to alloimmune reasons [PDF]

Гинекология, 2017
The article presents the current understanding of the pathogenetic mechanisms of habitual abortion realization of alloimmune genesis and proposed methods of immunotherapy. The mechanisms of the impact and effectiveness of various drugs and cell therapies.
V A Saribegova, N K Tetruashvili, L V Krechetova, A A Agadzhanova   +3 more
doaj  

CLINICAL-PHARMACOLOGICAL APECTS OF THE USE OF DYDROGESTERONE IN PREGNANCY MAINTENANCE

Акушерство, гинекология и репродукция, 2016
Dydrogesterone is a gestagen with proven pregnancy maintaining efficacy, which has been in common medical practice for more than 15 years in the Russian Federation and for more than 45 years outside of Russia.
E. V. Shikh
doaj  

Resolution of the I Ukrainian forum on miscarriages

Репродуктивная эндокринология
Today, there is an urgent need to develop and implement a regulatory document on abortion. This is due to the catastrophic state of reproduction of the Ukrainian population – the annual decrease in the number of labor, birth rates and the demographic ...
T.F. Tatarchuk, N.P. Honcharuk, N.Y. Pedachenko, D.H. Konkov, A.M. Kalinchuk, E.H. Manzhalii, T.K. Znamenska, T.M. Tutchenko, M.V. Haytovych   +8 more
doaj   +1 more source

Fewer good-quality cleavage embryos in dydrogesterone-primed ovarian stimulation compared to GnRH antagonist protocol in POSEIDON group 4 patients

Journal of the Formosan Medical Association
Objective: To compare the in vitro fertilization (IVF) outcomes of the progestin-primed ovarian stimulation (PPOS) protocol using dydrogesterone and the GnRH antagonist (GnRH-ant) protocol in POSEIDON group 4 patients.
Nguyen Thi Lien Huong, Bui Thi Hanh, Nguyen Thi Bich Van, Phi Thi Tu Anh, Hoang Bao Long, Le Duc Thang, Tran Thu Thuy, Nguyen Thi Minh Thu, Dang Tuan Anh, Phan Ngoc Quy, Le Quang Do, Than Trong Thach, Jean Noel Hugues, Do Van Tien, Le Hoang   +14 more
doaj   +1 more source